APA (7th ed.) Citation
Coria, L. M., Saposnik, L. M., Pueblas Castro, C., Castro, E. F., Bruno, L. A., Stone, W. B., . . . Cassataro, J. (2024). A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations containing alum increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection in mice. Frontiers Media.
Chicago Style (17th ed.) Citation
Coria, Lorena M., et al. A Novel Bacterial Protease Inhibitor Adjuvant in RBD-based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice. Frontiers Media, 2024.
MLA (9th ed.) Citation
Coria, Lorena M., et al. A Novel Bacterial Protease Inhibitor Adjuvant in RBD-based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice. Frontiers Media, 2024.
Warning: These citations may not always be 100% accurate.